Exposure to bacterial products lipopolysaccharide and flagellin and hepatocellular carcinoma: a nested case-control study.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Fedirko, VeronikaTran, Hao Quang
Gewirtz, Andrew T
Stepien, Magdalena
Trichopoulou, Antonia
Aleksandrova, Krasimira
Olsen, Anja
Tjønneland, Anne
Overvad, Kim
Carbonnel, Franck
Boutron-Ruault, Marie-Christine
Severi, Gianluca
Kühn, Tilman
Kaaks, Rudolf
Boeing, Heiner
Bamia, Christina
Lagiou, Pagona
Grioni, Sara
Panico, Salvatore
Palli, Domenico
Tumino, Rosario
Naccarati, Alessio
Peeters, Petra H
Bueno-de-Mesquita, H B
Weiderpass, Elisabete
Castaño, José María Huerta
Barricarte, Aurelio
Sánchez, María-José
Dorronsoro, Miren
Quirós, J Ramón
Agudo, Antonio
Sjöberg, Klas
Ohlsson, Bodil
Hemmingsson, Oskar
Werner, Mårten
Bradbury, Kathryn E
Khaw, Kay-Tee
Wareham, Nick
Tsilidis, Konstantinos K
Aune, Dagfinn
Scalbert, Augustin
Romieu, Isabelle
Riboli, Elio
Jenab, Mazda
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Exposure to bacterial products lipopolysaccharide and flagellin and hepatocellular carcinoma: a nested case-control study.Published in
BMC Med 2017; 15(1):72Publiekssamenvatting
Leakage of bacterial products across the gut barrier may play a role in liver diseases which often precede the development of liver cancer. However, human studies, particularly from prospective settings, are lacking.PMID
28372583ae974a485f413a2113503eed53cd6c53
10.1186/s12916-017-0830-8
Scopus Count
Collections
Related articles
- Biomarkers of gut barrier dysfunction and risk of hepatocellular carcinoma in the REVEAL-HBV and REVEAL-HCV cohort studies.
- Authors: Petrick JL, Florio AA, Zen J, Wang Y, Gewirtz AT, Pfeiffer RM, Loftus S, Inglefield J, Koshiol J, Yang B, Yu K, Hildesheim A, Chen CJ, Yang HI, Lee MH, McGlynn KA
- Issue date: 2023 Jul 1
- Serum Endotoxins and Flagellin and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort.
- Authors: Kong SY, Tran HQ, Gewirtz AT, McKeown-Eyssen G, Fedirko V, Romieu I, Tjønneland A, Olsen A, Overvad K, Boutron-Ruault MC, Bastide N, Affret A, Kühn T, Kaaks R, Boeing H, Aleksandrova K, Trichopoulou A, Kritikou M, Vasilopoulou E, Palli D, Krogh V, Mattiello A, Tumino R, Naccarati A, Bueno-de-Mesquita HB, Peeters PH, Weiderpass E, Quirós JR, Sala N, Sánchez MJ, Castaño JM, Barricarte A, Dorronsoro M, Werner M, Wareham NJ, Khaw KT, Bradbury KE, Freisling H, Stavropoulou F, Ferrari P, Gunter MJ, Cross AJ, Riboli E, Bruce WR, Jenab M
- Issue date: 2016 Feb
- Detectable serum flagellin and lipopolysaccharide and upregulated anti-flagellin and lipopolysaccharide immunoglobulins in human short bowel syndrome.
- Authors: Ziegler TR, Luo M, Estívariz CF, Moore DA 3rd, Sitaraman SV, Hao L, Bazargan N, Klapproth JM, Tian J, Galloway JR, Leader LM, Jones DP, Gewirtz AT
- Issue date: 2008 Feb
- Bacterial Translocation and Risk of Liver Cancer in a Finnish Cohort.
- Authors: Yang B, Petrick JL, Thistle JE, Pinto LA, Kemp TJ, Tran HQ, Gewirtz AT, Waterboer T, Fedirko V, Jenab M, Graubard BI, Weinstein SJ, Albanes D, McGlynn KA
- Issue date: 2019 Apr
- Elevations in serum anti-flagellin and anti-LPS Igs are related to growth faltering in young Tanzanian children.
- Authors: McDonald CM, Manji KP, Gosselin K, Tran H, Liu E, Kisenge R, Aboud S, Fawzi WW, Gewirtz AT, Duggan CP
- Issue date: 2016 Jun